Literature DB >> 5557913

Monitoring heparin therapy with the activated partial thromboplastin time.

R K Stuart, A Michel.   

Abstract

Difficulties associated with the whole blood clotting time (W.B.C.T.) as a method of monitoring heparin therapy have led to the investigation of the activated partial thromboplastin time (A.P.T.T.) as an alternative. The conclusion is reached that the latter procedure possesses several advantages. Using the method described and a citrate-preserved blood sample collected just prior to the administration of the next serial dose of heparin, the suggested therapeutic duration of the A.P.T.T. is 70 seconds or twice the mean control value. A practical range for this method is 60 to 70 seconds.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5557913      PMCID: PMC1930883     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  15 in total

1.  The partial thromboplastin time (cephalin time) in anticoagulation therapy.

Authors:  G P STRUVER; D L BITTNER
Journal:  Am J Clin Pathol       Date:  1962-11       Impact factor: 2.493

2.  Comparative effects of dicoumarol, tromexan, and heparin on thrombus propagation.

Authors:  L C CAREY; R D WILLIAMS
Journal:  Ann Surg       Date:  1960-11       Impact factor: 12.969

3.  Studies in intravascular coagulation. IV. The effect of heparin and dicumarol on serum-induced venous thrombosis.

Authors:  S WESSLER; L E MORRIS
Journal:  Circulation       Date:  1955-10       Impact factor: 29.690

4.  Laboratory control of heparin therapy with the activated partial thromboplastin time test.

Authors:  T J Degnan; S Karasik; J Lenahan
Journal:  Curr Ther Res Clin Exp       Date:  1969-06

Review 5.  Some guidelines for heparin therapy of venous thromboembolic disease.

Authors:  V Gurewich; D P Thomas; R K Stuart
Journal:  JAMA       Date:  1967-01-09       Impact factor: 56.272

6.  Activated partial thromboplastin time test in heparin therapy. A study.

Authors:  A Simmons; D E Cross
Journal:  Mo Med       Date:  1969-06

7.  Current concepts: the use of heparin.

Authors:  D Deykin
Journal:  N Engl J Med       Date:  1969-04-24       Impact factor: 91.245

8.  Control of heparin therapy. Sensitivity of the activated partial thromboplastin time for monitoring the antithrombotic effects of heparin.

Authors:  S Zucker; M H Cathey
Journal:  J Lab Clin Med       Date:  1969-02

9.  Pathogenesis of venous thrombosis in relation to its prevention by dextran and heparin.

Authors:  V Gurewich; D P Thomas
Journal:  J Lab Clin Med       Date:  1965-10

10.  Use of the activated partial thromboplastin time in the control of heparin administration.

Authors:  J G Lenaham; S Frye; G E Phillips
Journal:  Clin Chem       Date:  1966-05       Impact factor: 8.327

View more
  2 in total

1.  Heparin in clinical medicine.

Authors:  D L Levene
Journal:  Can Fam Physician       Date:  1973-02       Impact factor: 3.275

Review 2.  Antithrombotic drugs: part I.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.